| |
| |
|
| Insider
Information: |
Crystal Roger |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
19,623 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$161,497 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
19,623 |
|
|
| Total
Value |
$161,497 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
6
|
|
Stock
price went up :
|
0
|
4
|
| Stock
price went down : |
1
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
2.0
|
| Percentage
Gain/Loss : |
 -45.2%
|
-40.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Opiant Pharmaceuticals Inc |
OPNT |
Chief Executive Office... |
2023-03-02 |
0 |
|
0 |
Premium* |
|
|
Mind Medicine |
MNMD |
Director |
2023-06-21 |
19,623 |
2022-08-11 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MNMD |
Mind Medicine |
Director |
– • – |
2022-08-11 |
4 |
A |
$0.00 |
$0 |
D/D |
89,286 |
89,286 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Executive Officer |
• • • |
2022-06-27 |
4 |
A |
$0.00 |
$0 |
D/D |
6,667 |
85,155 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Executive Officer |
• • • |
2022-07-14 |
4 |
S |
$11.11 |
$24,953 |
D/D |
(2,246) |
82,909 |
0 |
% |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Executive Officer |
• • • |
2022-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
81,541 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Executive Officer |
• • • |
2022-01-10 |
4 |
S |
$30.49 |
$32,258 |
D/D |
(1,058) |
80,483 |
0 |
% |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Executive Officer |
• • • |
2022-01-27 |
4 |
S |
$26.15 |
$52,169 |
D/D |
(1,995) |
78,488 |
0 |
% |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Executive Officer |
• • • |
2023-01-05 |
4 |
S |
$20.20 |
$101,586 |
D/D |
(5,029) |
77,880 |
0 |
% |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Executive Officer |
• • • |
2023-01-09 |
4 |
S |
$20.20 |
$23,897 |
D/D |
(1,183) |
76,697 |
0 |
% |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Executive Officer |
• • • |
2023-01-27 |
4 |
S |
$20.26 |
$27,513 |
D/D |
(1,358) |
75,339 |
0 |
% |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Executive Officer |
• • • |
2019-01-07 |
4 |
OE |
$6.00 |
$212,647 |
D/D |
33,641 |
46,641 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Executive Officer |
• • • |
2021-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
19,416 |
41,541 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Executive Officer |
• • • |
2018-10-02 |
4 |
OE |
$7.25 |
$212,403 |
D/D |
29,297 |
37,772 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Executive Officer |
• • • |
2019-04-05 |
4 |
OE |
$7.25 |
$155,672 |
D/D |
21,472 |
37,248 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Executive Officer |
• • • |
2019-04-04 |
4 |
OE |
$7.25 |
$163,538 |
D/D |
22,557 |
32,612 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Executive Officer |
• • • |
2018-10-02 |
4 |
AS |
$17.51 |
$177,621 |
D/D |
(10,144) |
27,628 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Executive Officer |
• • • |
2019-01-04 |
4 |
OE |
$7.25 |
$118,603 |
D/D |
16,359 |
24,834 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Executive Officer |
• • • |
2018-10-03 |
4 |
AS |
$19.23 |
$82,689 |
D/D |
(4,300) |
23,328 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Executive Officer |
• • • |
2020-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
13,650 |
22,125 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Executive Officer |
• • • |
2019-04-05 |
4 |
AS |
$11.98 |
$191,692 |
D/D |
(16,001) |
21,247 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Executive Officer |
• • • |
2019-01-07 |
4 |
AS |
$13.28 |
$355,360 |
D/D |
(26,759) |
19,882 |
0 |
- |
|
| MNMD |
Mind Medicine |
Director |
– • – |
2023-06-21 |
4 |
A |
$0.00 |
$0 |
D/D |
13,671 |
19,623 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Executive Officer |
• • • |
2018-10-04 |
4 |
AS |
$18.43 |
$73,831 |
D/D |
(4,006) |
19,322 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Executive Officer |
• • • |
2018-10-05 |
4 |
AS |
$18.14 |
$15,365 |
D/D |
(847) |
18,475 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Executive Officer |
• • • |
2019-04-04 |
4 |
AS |
$11.93 |
$200,853 |
D/D |
(16,836) |
15,776 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Executive Officer |
• • • |
2018-10-08 |
4 |
AS |
$17.33 |
$53,012 |
D/D |
(3,059) |
15,416 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
